192 related articles for article (PubMed ID: 24996905)
1. Mutations in HAO1 encoding glycolate oxidase cause isolated glycolic aciduria.
Frishberg Y; Zeharia A; Lyakhovetsky R; Bargal R; Belostotsky R
J Med Genet; 2014 Aug; 51(8):526-9. PubMed ID: 24996905
[TBL] [Abstract][Full Text] [Related]
2. Glycolate oxidase deficiency in a patient with congenital hyperinsulinism and unexplained hyperoxaluria.
Clifford-Mobley O; Rumsby G; Kanodia S; Didi M; Holt R; Senniappan S
Pediatr Nephrol; 2017 Nov; 32(11):2159-2163. PubMed ID: 28752386
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1.
Dutta C; Avitahl-Curtis N; Pursell N; Larsson Cohen M; Holmes B; Diwanji R; Zhou W; Apponi L; Koser M; Ying B; Chen D; Shui X; Saxena U; Cyr WA; Shah A; Nazef N; Wang W; Abrams M; Dudek H; Salido E; Brown BD; Lai C
Mol Ther; 2016 Apr; 24(4):770-8. PubMed ID: 26758691
[TBL] [Abstract][Full Text] [Related]
4. Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II.
Monico CG; Persson M; Ford GC; Rumsby G; Milliner DS
Kidney Int; 2002 Aug; 62(2):392-400. PubMed ID: 12110000
[TBL] [Abstract][Full Text] [Related]
5. L-glyceric aciduria. A new genetic variant of primary hyperoxaluria.
Williams HE; Smith LH
N Engl J Med; 1968 Feb; 278(5):233-8. PubMed ID: 5635456
[No Abstract] [Full Text] [Related]
6. The synthesis of oxylate from hydroxypyruvate by isolated perfused rat liver. The mechanism of hyperoxaluria in L-glyceric aciduria.
Liao LL; Richardson KE
Biochim Biophys Acta; 1978 Jan; 538(1):76-86. PubMed ID: 620064
[TBL] [Abstract][Full Text] [Related]
7. Glycolate Oxidase Is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I.
Martin-Higueras C; Luis-Lima S; Salido E
Mol Ther; 2016 Apr; 24(4):719-25. PubMed ID: 26689264
[TBL] [Abstract][Full Text] [Related]
8. Hyperoxaluria in L-glyceric aciduria: possible pathogenic mechanism.
Williams HE; Smith LH
Science; 1971 Jan; 171(3969):390-1. PubMed ID: 4321474
[TBL] [Abstract][Full Text] [Related]
9. Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria.
McGregor TL; Hunt KA; Yee E; Mason D; Nioi P; Ticau S; Pelosi M; Loken PR; Finer S; Lawlor DA; Fauman EB; Huang QQ; Griffiths CJ; MacArthur DG; Trembath RC; Oglesbee D; Lieske JC; Erbe DV; Wright J; van Heel DA
Elife; 2020 Mar; 9():. PubMed ID: 32207686
[TBL] [Abstract][Full Text] [Related]
10. Improving Treatment Options for Primary Hyperoxaluria.
Hoppe B; Martin-Higueras C
Drugs; 2022 Jul; 82(10):1077-1094. PubMed ID: 35779234
[TBL] [Abstract][Full Text] [Related]
11. The effects of the inactivation of Hydroxyproline dehydrogenase on urinary oxalate and glycolate excretion in mouse models of primary hyperoxaluria.
Buchalski B; Wood KD; Challa A; Fargue S; Holmes RP; Lowther WT; Knight J
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165633. PubMed ID: 31821850
[TBL] [Abstract][Full Text] [Related]
12. Severe child form of primary hyperoxaluria type 2 - a case report revealing consequence of GRHPR deficiency on metabolism.
Konkoľová J; Chandoga J; Kováčik J; Repiský M; Kramarová V; Paučinová I; Böhmer D
BMC Med Genet; 2017 May; 18(1):59. PubMed ID: 28569194
[TBL] [Abstract][Full Text] [Related]
13. The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II.
Cramer SD; Ferree PM; Lin K; Milliner DS; Holmes RP
Hum Mol Genet; 1999 Oct; 8(11):2063-9. PubMed ID: 10484776
[TBL] [Abstract][Full Text] [Related]
14. An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.
Liebow A; Li X; Racie T; Hettinger J; Bettencourt BR; Najafian N; Haslett P; Fitzgerald K; Holmes RP; Erbe D; Querbes W; Knight J
J Am Soc Nephrol; 2017 Feb; 28(2):494-503. PubMed ID: 27432743
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a New Gas Chromatography-Tandem Mass Spectrometry Method for the Measurement of Enrichment of Glyoxylate Metabolism Analytes in Hyperoxaluria Patients Using a Stable Isotope Procedure.
van Harskamp D; Garrelfs SF; Oosterveld MJS; Groothoff JW; van Goudoever JB; Schierbeek H
Anal Chem; 2020 Jan; 92(2):1826-1832. PubMed ID: 31867958
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.
Milliner DS; Wilson DM; Smith LH
Kidney Int; 2001 Jan; 59(1):31-6. PubMed ID: 11135054
[TBL] [Abstract][Full Text] [Related]
17. Response to a physiologic dose of pyridoxine in type I primary hyperoxaluria.
Yendt ER; Cohanim M
N Engl J Med; 1985 Apr; 312(15):953-7. PubMed ID: 3974685
[TBL] [Abstract][Full Text] [Related]
18. Biogenesis of L-glyceric aciduria, oxalosis and renal injury in rats simulating type II primary hyperoxaluria.
Raghavan KG; Lathika KM; Gandhi NM; D'Souza SJ; Tarachand U; Ramakrishnan V; Singh BB
Biochim Biophys Acta; 1997 Dec; 1362(2-3):97-102. PubMed ID: 9540839
[TBL] [Abstract][Full Text] [Related]
19. Endogenous Oxalate Production in Primary Hyperoxaluria Type 1 Patients.
Garrelfs SF; van Harskamp D; Peters-Sengers H; van den Akker CHP; Wanders RJA; Wijburg FA; van Goudoever JB; Groothoff JW; Schierbeek H; Oosterveld MJS
J Am Soc Nephrol; 2021 Dec; 32(12):3175-3186. PubMed ID: 34686543
[TBL] [Abstract][Full Text] [Related]
20. Urinary oxalate, glycolate, glyoxylate, and citrate after acute intravenous administration of glyoxylate in rats.
Ogawa Y; Miyazato T; Morozumi M; Sugaya K; Hatano T
Mol Urol; 2000; 4(4):341-8. PubMed ID: 11156701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
